We are thrilled that we have presented at the ISSRDC conference in Boston with our groundbreaking study: “Encapsulate: Automated Biochips for Personalized Cancer Screening in Microgravity”.
For the first time, we’ll be sharing the incredible data achieved from our research on the International Space Station, as part of the SpaceX CRS-30 mission. This study represents the effects of microgravity on patient responses to a variety of chemodrugs, and is a huge leap forward in personalized cancer therapy, utilizing microgravity to enhance our automated biochips’ capabilities.
Join us as we explore how microgravity can revolutionize cancer screening and treatment, pushing the boundaries of what’s possible in space and medicine.
hashtag#ISSRDC2024
hashtag#CancerResearch
hashtag#SpaceMedicine
hashtag#Microgravity
